Background The incidence of complications after implantable cardioverter-defibrillator (ICD)
and cardiac resynchronisation therapy (CRT-D) implantations is dependent on the number …

Background We compared clinical and technical outcome of CRT recipients treated either
with a conventional 3‑leads (3L) CRTD or with the new 2‑leads (DX) CRTD that enables …

Introduction The novel two‐lead cardiac resynchronization therapy (CRT)‐DX system
utilizes a floating atrial dipole on the implantable cardioverter‐defibrillator lead, and when …

Aims Cardiac resynchronization therapy (CRT) is sometimes complicated by elevated
pacing thresholds and phrenic nerve stimulation (PNS), both of which may require that the …

Implantable cardioverter–defibrillator (ICD) and cardiac resynchronisation therapy (CRT) is
generally limited to transvenous techniques especially in pacing-dependant patients. We …

A 63-year-old man with nonischemic, dilated cardiomyopathy, left ventricular ejection
fraction of 15%, New York Heart Association class III heart-failure symptoms, and …

Background Two-lead cardiac resynchronization therapy with DX technology (CRT-DX) has
been demonstrated to provide adequate resynchronization therapy equivalent to …

Background The concept of a single‐lead dual‐chamber implantable cardioverter
defibrillator (ICD) with floating sensing atrial dipole has been proven safe and functional. We …

Abstract Aims The ALternate Site Cardiac ResYNChronization (ALSYNC) study evaluated
the feasibility and safety of left ventricular endocardial pacing (LVEP) using a market …

Introduction: Atrial Fibrillation (AF) is an important contributor to insufficient left ventricular
pacing and mortality in patients undergoing cardiac resynchronization therapy (CRT). The …